PEAK PHARMACEUTICALS, INC. (RMHI) Net income 2013–2022
PEAK PHARMACEUTICALS, INC. (RMHI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$164,969FY2022 · since FY2013: -$12,341 → -$164,969
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$164,969 | -116.8% |
| FY2021 | -$76,089 | -406.9% |
| FY2020 | -$15,011 | -7.3% |
| FY2019 | -$13,993 | +50.7% |
| FY2018 | -$28,407 | +44.5% |
| FY2017 | -$51,227 | -104.4% |
| FY2016 | $1.2M | +150.4% |
| FY2015 | -$2.3M | +38.6% |
| FY2014 | -$3.8M | -30357.9% |
| FY2013 | -$12,341 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RMHI financial trends
RMHI RevenueRMHI Net marginRMHI Gross profitRMHI Gross marginRMHI Operating incomeRMHI Operating marginRMHI Operating cash flowRMHI Free cash flowRMHI Capital expendituresRMHI Return on equityRMHI Stock buybacksRMHI Dividends paidRMHI Total assetsRMHI Total liabilitiesRMHI Shareholders’ equityRMHI overview →